🩸 Stent Retriever Clot Extraction Technique Simulator

Femoral or Radial Access and Guide Catheter Navigation to the Cervical Carotid

Mechanical thrombectomy begins far from the brain: with a needle puncture in the groin or wrist. Establishing a stable, large-bore conduit from the periphery to the cervical carotid artery is the mechanical foundation on which every subsequent step of the procedure depends — without a secure guide catheter position, no device can be delivered reliably to the occlusion.

• ~90 min: Median door-to-groin time (comprehensive stroke centers)
• Rising: Transradial adoption (lower access-site complications)
• 6–9 Fr: Guide catheter caliber (matched to device/aspiration needs)
• <2%: Access-site complication rate (hematoma, pseudoaneurysm, dissection)

Femoral vs. transradial access

Common femoral artery (CFA) access remains the workhorse approach for neurointervention: a large, reliably palpable vessel that accommodates 8–9 Fr guide sheaths and balloon guide catheters with minimal resistance.

Transradial access (TRA) is increasingly favored, particularly for patients with tortuous or diseased aortic arches, obesity, or prior femoral complications: • Lower access-site bleeding and pseudoaneurysm rates • Immediate ambulation post-procedure (no prolonged bed rest) • Patient preference and comfort • Limitation: smaller sheath sizes constrain balloon guide catheter options in some systems

Ultrasound-guided micropuncture technique is standard for either site, reducing inadvertent arterial injury and minimizing the number of needle passes.

Navigating the aortic arch and great vessels

Once sheath access is secured, a diagnostic catheter and hydrophilic guidewire are advanced retrograde through the iliac artery, abdominal and thoracic aorta, and into the aortic arch under fluoroscopic roadmap guidance.

Aortic arch anatomy is classified by the vertical drop of the great vessel origins relative to the top of the arch (Type I, II, III) — more acute, "elongated" arches (common in elderly patients) markedly increase catheterization difficulty and procedure time.

The guide catheter or long sheath is then selectively advanced into the target great vessel (common carotid, subclavian → vertebral) and finally into the cervical internal carotid artery (ICA), typically to the C1–C2 vertebral level — proximal enough to avoid vessel injury, distal enough to provide a stable, low-friction platform for the microcatheter and thrombectomy device.

A balloon guide catheter (BGC), inflated in the cervical ICA just before retrieval, is one of the most consequential adjuncts in modern thrombectomy: by transiently arresting antegrade flow (and enabling proximal aspiration) it prevents clot fragments from embolizing into new, previously unaffected territories during withdrawal — improving first-pass success and functional outcomes across multiple registries.

Microcatheter and Microwire Navigation Across the Occlusive Thrombus

With the guide catheter positioned in the cervical carotid, a much smaller and more flexible microcatheter–microwire pair takes over navigation into the fragile intracranial circulation, gently probing and traversing the thrombus itself — a step that demands exquisite tactile control to avoid vessel perforation in already-ischemic, friable tissue.

• ~2.4–2.8 Fr: Microcatheter outer diameter (0.021–0.027" lumen)
• ~0.014": Microwire tip diameter (soft, steerable J-tip)
• 2–8 min: Typical crossing time (occlusion-dependent)
• <1%: Vessel perforation risk (per crossing attempt)

Roadmap navigation through intracranial tortuosity

A digital subtraction roadmap is generated by injecting contrast through the guide catheter, outlining the patent vessel lumen up to the point of occlusion. The microwire is then advanced under continuous or step-wise fluoroscopy, its soft, pre-shaped tip torqued to negotiate the carotid siphon and M1/M2 bifurcation angles.

Key technical principles: • The microwire always leads; the microcatheter follows over the wire, never advanced independently against resistance • Gentle, controlled forward pressure — never force — through the thrombus interface; excessive force risks subintimal dissection or perforation through the already-compromised vessel wall • Frequent small contrast puffs ("puff and pull") confirm the wire remains intraluminal, not subintimal

Confirming true-lumen crossing distal to the clot

Successful crossing is confirmed when the microwire tip passes the occlusion and a small distal contrast injection through the microcatheter opacifies normal-caliber vessel beyond the clot, without extravasation or a "railroad track" subintimal pattern.

This distal confirmation is essential: it verifies the working space for stent retriever deployment is a genuine, intraluminal channel through — not around — the thrombus, which is required for the device to engage and interdigitate with the full clot burden rather than merely displacing it.

In tortuous or heavily calcified anatomy, an intermediate ("distal access") catheter is often advanced coaxially over the microcatheter partway through the vessel, providing additional support and a stable platform for subsequent aspiration.

Stent Retriever Deployment — Radial Expansion and Clot Interdigitation

The stent retriever is the signature device of modern mechanical thrombectomy: a self-expanding, laser-cut nitinol mesh delivered collapsed inside the microcatheter, then unsheathed directly across the thrombus. As it expands to native vessel diameter, its struts do not simply push the clot aside — they interpenetrate the fibrin-platelet matrix, mechanically capturing it for extraction.

• Solitaire, 2012: First device (FDA) (also Trevo, EmboTrap, Tigertriever)
• ~55% Ni / 45% Ti: Nitinol composition (shape-memory alloy)
• 20–40 mm: Deployed length (spans clot + healthy margin)
• Seconds: Time to partial reflow (upon full expansion)

Nitinol self-expansion and mesh–clot mechanics

Stent retrievers are cut from a single nitinol tube using femtosecond laser technology, producing an open-cell or closed-cell mesh with programmed shape memory. Constrained inside the microcatheter in a low-profile collapsed state, the device is deployed by holding the delivery wire stationary while withdrawing the microcatheter — the mesh expands outward at body temperature to its nominal diameter (typically 4–6 mm) as the constraint is released.

As the struts radially expand within the thrombus, three things happen more or less simultaneously: • Struts press outward against the vessel wall, compressing the clot into the interstices of the mesh — physical interdigitation, not just contact • The compressed clot is pinned between strut and vessel wall, transferring grip force along the full device length • Blood immediately begins flowing through the newly opened channel, often producing partial ("first-touch") reperfusion even before retrieval begins

Sizing, positioning, and dwell time

Device diameter is chosen 1–2 mm larger than the target vessel to ensure adequate wall apposition and clot engagement without oversizing that risks vessel injury. Length is selected to span the clot with a margin of normal vessel proximal and distal, ensuring struts anchor into healthy endothelium rather than clot alone at either end.

After deployment, an optional dwell time (typically 3–5 minutes) is often observed before retrieval begins, allowing the mesh to more fully integrate with the clot matrix — friable, poorly organized thrombus interdigitates rapidly, while densely fibrin-rich or organized (older, more retracted) clot integrates more slowly and less completely, directly influencing first-pass success.

Clot composition drives device performance more than any single technical variable: red blood cell-rich thrombus is soft and compresses easily into the stent mesh, while fibrin/platelet-rich ("white") thrombus is firmer, more elastic, and prone to slipping out of the mesh interstices during retrieval — often requiring adjunctive aspiration or multiple passes.

Retrieval Under Flow Arrest and Aspiration

Deploying the stent is only half the procedure — the clot must now be withdrawn from the intracranial circulation without shedding fragments into new vascular territory. Retrieval technique, and specifically the use of proximal flow arrest and aspiration, is one of the largest modifiable determinants of both first-pass success and the risk of iatrogenic distal embolization.

• +10–15%: Balloon guide catheter benefit (absolute first-pass success)
• Stent + aspiration: "Solumbra" combined technique (catheter advanced to clot face)
• Slow, steady: Withdrawal speed (device + microcatheter as unit)
• ~15%: New-territory embolization (no BGC) (vs. ~5–9% with flow arrest)

Flow arrest with a balloon guide catheter

Just before retrieval, the compliant balloon at the tip of the guide catheter is inflated in the cervical ICA, occluding antegrade flow. This single maneuver converts a high-flow arterial segment into a low-flow, controlled column, so that any clot fragment dislodged during withdrawal is far less likely to be swept downstream into a new, previously unaffected branch.

With flow arrested, the guide catheter is often placed on continuous manual or pump aspiration, generating retrograde flow that actively draws blood — and any liberated debris — backward, out of the intracranial circulation entirely, rather than allowing it to embolize distally.

Combined stent retriever + aspiration ("Solumbra"/SAVE) technique

Contemporary thrombectomy increasingly combines the stent retriever with a large-bore aspiration catheter advanced to the clot face — the stent is deployed through the aspiration catheter, and both are withdrawn together while continuous aspiration is applied at the catheter tip.

This combined approach: • Provides an aspiration "vacuum" immediately adjacent to the clot, capturing fragments that slip from the stent mesh • Shortens the unprotected distance the clot must travel through native vessel before reaching a protected system • Has been associated with higher first-pass effect (FPE) rates than either stent retriever or aspiration alone in several comparative studies

Withdrawal mechanics and multiple-pass strategy

The stent, still loaded with clot, is withdrawn slowly and steadily as a unit with the microcatheter into the guide/aspiration catheter, maintaining continuous aspiration throughout. Once inside the larger catheter lumen, the entire assembly — catheter, stent, and clot — is removed from the patient together, and only then is the balloon deflated to restore flow, followed by an angiographic run to assess the result.

If a single pass fails to achieve substantial reperfusion, additional passes are performed — but each subsequent pass carries diminishing incremental benefit and a rising cumulative risk of vessel injury, vasospasm, and distal embolization. The interventionalist must weigh continued attempts against the well-documented principle that the very first pass carries the best chance of a clean, complication-free result.

Recanalization Confirmation and the TICI Reperfusion Scale

The procedure concludes with objective, angiographic proof of success — or failure. A final contrast run through the guide catheter is graded using the modified Thrombolysis in Cerebral Infarction (mTICI) scale, the standardized language interventionalists, trialists, and stroke neurologists use to describe how completely flow has been restored to the previously ischemic territory.

• ≥50–100%: TICI 2b/3 = success threshold (territory reperfused)
• ~85–90%: Successful recanalization rate (contemporary large trials)
• ~25–50%: First-pass effect (FPE) (TICI 2c/3 on pass 1)
• ~2.6: NNT for functional independence (HERMES pooled meta-analysis)

The modified TICI reperfusion grading scale

mTICI grading is assessed on the final angiographic run and drives both clinical decision-making (stop vs. continue) and trial endpoint reporting:

• TICI 0 — No perfusion; no antegrade flow beyond the occlusion • TICI 1 — Minimal perfusion; contrast passes the occlusion but fails to opacify the distal territory • TICI 2a — Partial perfusion; <50% of the affected territory is filled • TICI 2b — Partial perfusion; ≥50% of the territory is filled • TICI 2c — Near-complete perfusion; small distal emboli or slow flow persist • TICI 3 — Complete perfusion; the entire territory fills normally with no residual occlusion

TICI 2b, 2c, and 3 are collectively considered "successful reperfusion" and, in the great majority of cases, end the procedure — further passes to convert a 2b into a 3 are not always pursued, since incremental gains must be weighed against added procedural risk.

The first-pass effect and its clinical importance

The "first-pass effect" (FPE) — achieving TICI 2c/3 reperfusion on the very first device pass — has emerged as one of the strongest predictors of good functional outcome in mechanical thrombectomy, independent of the number of subsequent passes needed to eventually reach the same angiographic result.

Patients who achieve FPE have significantly higher rates of 90-day functional independence (modified Rankin Scale 0–2) than those requiring multiple passes to reach an identical final TICI grade — reinforcing that procedural efficiency and technique optimization (device selection, aspiration adjuncts, flow arrest) carry real neurological consequences beyond the angiographic endpoint alone.

Landmark trials — MR CLEAN, SWIFT PRIME, ESCAPE, EXTEND-IA, REVASCAT, and later DAWN and DEFUSE 3 (which extended the treatment window to 24 hours using perfusion-imaging selection) — collectively transformed mechanical thrombectomy from an experimental therapy into the standard of care for large-vessel occlusion stroke, with a number-needed-to-treat of roughly 2.6 for improved functional outcome, among the most effective interventions in modern medicine.